How PEMF can help you
NeoRhythm is compliant with the Medical Device Regulation: Regulation (EU) 2017/745, Annex XVI, which revises the requirements for design, safety and performance standards of devices with both medical and non-medical purposes.
When to expect results
The majority of users can expect to feel the results in one to two weeks of using NeoRhythm on a daily basis. The time it takes for you to notice the results may vary significantly from person to person, depending on several factors, such as your biorhythm, stress levels, health condition, etc
Yes, NeoRhythm is compliant with the European Union Medical Device Regulation: Regulation (EU) 2017/745, Annex XVI, which revises the requirements for design, safety and performance standards of devices with both medical and non-medical purposes. The safety and effective performance of the device are guaranteed.
NeoRhythm emits non-invasive low-frequency electromagnetic waves, stimulating the cells and neurones based on a medical-grade pulsed electromagnetic field (PEMF) technology.
NeoRhythm is app- and gesture-controlled. Connect it to your smartphone and choose between seven different programs or create your own custom program.
The application of PEMF therapy has no harmful side effects, either short or long-term ones.
We are confident that you are going to love your NeoRhythm. That is why MDCN Tech Ltd. offers a 60-day money-back guarantee, which starts with the day when you receive your device. If you are not satisfied with the results, send us your NeoRhythm back for a full refund.
Each customer gets all they need for the safe and comfortable use of NeoRhythm. Shipping is free, while any import duties and taxes are the sole responsibility of the buyer. For the US there is no tax on all purchases under $ 800. NeoRhythm is also tax-free in EU.
While most devices on the market are EEG-based and only track your brain activity, NeoRhythm is the only brain entrainment device that uses non-invasive pulsed electromagnetic waves to create an ideal atmosphere for your mind and body.
NeoRhythm is generally safe for use. However, people with certain medical conditions SHOULD NOT use the device:
- People with pacemakers or other electronic implants, cochlear implants, or mechanical heart valves
- People under 12 years of age
- Safety of PEMFs has not been established in pregnancy, although there is no evidence of harm. Most manufacturers warn against the use of their device during pregnancy.
We suggest consulting your healthcare professional before using NeoRhythm by Omnipemf if you have any medical condition or any concerns regarding the use of such technology.
Yes. The device does not negatively interact with any medication.
More than 17.000 users are using NeoRhythm (and growing). If you would like to ask NeoRhythm users directly about their experience please join our Omnipemf community.
PEMF stands for Pulsed Electromagnetic Field. Devices that utilize PEMF technology emit electromagnetic waves at different frequencies in order to stimulate and encourage your body’s natural recovery process.
Put simply, NeoRhythm is a PEMF device. PEMF technology has a 60+ years long track record of clinical success in different fields. Since 1979 FDA has approved PEMF therapy to heal non-union fractures, pain, incontinence, muscle stimulation, depression, anxiety and several other diseases. But never before has PEMF been made into a device that is suitable for home use, simple and easy to use.
“Tests in our clinic have demonstrated effective stress reduction and anti-aging effects, after only 15 minutes therapy. I am a health professional with 12 years experience in electromedical devices.”
Improve your well-being and quality of life with NeoRhythm.
Made for active individuals – both physically and mentally – NeoRhythm will help you de-stress, focus, energize your body, sleep & meditate better. It may help you deal with your chronic or acute pain more effectively.
In the press
“This is a must-have when traveling.”
Maja Hoock, journalist: “Incredible: The stinging office back pain is subsiding.”